ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
13.16
+0.08 (0.61%)
At close: Jul 26, 2024, 4:00 PM
13.13
-0.03 (-0.23%)
After-hours: Jul 26, 2024, 6:59 PM EDT
ADMA Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Net Income | -3.64 | -28.24 | -65.9 | -71.65 | -75.75 | -48.28 | Upgrade
|
| Depreciation & Amortization | 8.4 | 8.32 | 7.11 | 5.5 | 3.94 | 3.26 | Upgrade
|
| Other Amortization | 2.37 | 2.6 | 2.4 | 1.9 | 1.78 | 1.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.19 | 0.18 | 0.43 | 0.22 | 0.08 | -11.32 | Upgrade
|
| Stock-Based Compensation | 7.22 | 6.19 | 5.22 | 3.49 | 2.86 | 2.65 | Upgrade
|
| Other Operating Activities | 28.89 | 29.87 | 9.53 | -0.14 | -1.13 | 9.82 | Upgrade
|
| Change in Accounts Receivable | -23.1 | -11.92 | 13.07 | -15.34 | -9.77 | -2.08 | Upgrade
|
| Change in Inventory | -13.75 | -9.63 | -38.56 | -43.19 | -28.47 | -34.65 | Upgrade
|
| Change in Accounts Payable | 4.56 | 3.84 | 0.8 | 1.36 | 1.9 | 3.27 | Upgrade
|
| Change in Other Net Operating Assets | 10.18 | 7.58 | 6.4 | 5.49 | 2.56 | -0.05 | Upgrade
|
| Operating Cash Flow | 21.31 | 8.8 | -59.51 | -112.37 | -102 | -76.19 | Upgrade
|
| Capital Expenditures | -5.17 | -4.77 | -13.91 | -13.51 | -12.73 | -3.81 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.23 | -0.21 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -5.4 | -4.98 | -13.91 | -13.51 | -12.72 | -3.81 | Upgrade
|
| Long-Term Debt Issued | - | 135 | 151.75 | - | 27.5 | 72.5 | Upgrade
|
| Total Debt Issued | 135 | - | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -158.6 | -100.04 | -0.03 | -13.98 | -30.03 | Upgrade
|
| Total Debt Repaid | -158.59 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -23.59 | -23.6 | 51.71 | -0.03 | 13.52 | 42.47 | Upgrade
|
| Issuance of Common Stock | 2.13 | 1.1 | 64.82 | 121.14 | 131.21 | 48.47 | Upgrade
|
| Repurchase of Common Stock | -3.25 | -1.42 | -2.9 | -0.06 | - | - | Upgrade
|
| Other Financing Activities | -15.08 | -15.08 | -4.78 | - | -0.83 | -10.94 | Upgrade
|
| Financing Cash Flow | -39.79 | -38.99 | 108.85 | 121.05 | 143.9 | 80 | Upgrade
|
| Net Cash Flow | -23.88 | -35.17 | 35.43 | -4.83 | 29.17 | -0 | Upgrade
|
| Free Cash Flow | 16.13 | 4.03 | -73.42 | -125.88 | -114.73 | -80.01 | Upgrade
|
| Free Cash Flow Margin | 5.70% | 1.56% | -47.65% | -155.52% | -271.74% | -272.60% | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.02 | -0.37 | -0.90 | -1.33 | -1.47 | Upgrade
|
| Cash Interest Paid | 14 | 18.05 | 13.88 | 11.16 | 10.27 | 8.11 | Upgrade
|
| Levered Free Cash Flow | 7.84 | 0.38 | -53.5 | -96.39 | -80.49 | -61.32 | Upgrade
|
| Unlevered Free Cash Flow | 19.66 | 13.43 | -43.85 | -90.13 | -74.78 | -56.88 | Upgrade
|
| Change in Net Working Capital | 19.99 | 11.38 | 17.67 | 49.62 | 32.97 | 33.09 | Upgrade
|
Source: S&P Capital IQ. Standard template.